Skip to content
10-Q

Quarterly Report

Petros Pharmaceuticals, Inc. PTPI

0001410578-25-001811

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 13, 2025 42.37M sh
Shares Diluted Q2 2025 · Jun 30, 2025 25.92M sh
Shares Diluted Q2 2025 · Jun 30, 2025 13.61M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 295.52K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 242.89K sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$4.67M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$2.8M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $7.32M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $1.72M
Stockholders Equity Q2 2025 · Jun 30, 2025 $4.45M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$9.58M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$7.47M
Stockholders Equity Q2 2025 · Jun 30, 2024 $8.07M
Stockholders Equity Q2 2025 · Mar 31, 2024 $9.79M
Stockholders Equity Q2 2025 · Dec 31, 2023 $12.07M
Current Liabilities Q2 2025 · Jun 30, 2025 $2.95M
Current Liabilities Q2 2025 · Dec 31, 2024 $18.03M
Total Liabilities Q2 2025 · Jun 30, 2025 $2.95M
Total Liabilities Q2 2025 · Dec 31, 2024 $18.1M
Current Assets Q2 2025 · Jun 30, 2025 $7.4M
Current Assets Q2 2025 · Dec 31, 2024 $7.29M
Total Assets Q2 2025 · Jun 30, 2025 $7.4M
Total Assets Q2 2025 · Dec 31, 2024 $10.64M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.29
Eps Diluted Q2 2025 · Jun 30, 2025 −$3.26
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$9.25
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$44.31
Eps Basic Q2 2025 · Jun 30, 2025 −$1.29
Eps Basic Q2 2025 · Jun 30, 2025 −$3.26
Eps Basic restated Q2 2025 · Jun 30, 2024 −$9.25
Eps Basic restated Q2 2025 · Jun 30, 2024 −$44.31
Sga Expense Q2 2025 · Jun 30, 2025 $1.8M
Sga Expense Q2 2025 · Jun 30, 2025 $3.26M
Sga Expense restated Q2 2025 · Jun 30, 2024 $1.35M
Sga Expense restated Q2 2025 · Jun 30, 2024 $2.85M
Net Income Q2 2025 · Jun 30, 2025 $5.43M
Net Income Q2 2025 · Jun 30, 2025 $3.17M
Net Income Q2 2025 · Jun 30, 2024 −$662.03K
Net Income Q2 2025 · Jun 30, 2024 −$2.82M
Operating Income Q2 2025 · Jun 30, 2025 −$1.8M
Operating Income Q2 2025 · Jun 30, 2025 −$3.26M
Operating Income restated Q2 2025 · Jun 30, 2024 −$1.35M
Operating Income restated Q2 2025 · Jun 30, 2024 −$2.85M